A former OpenAI researcher, Miles Wang, has left the company to co-found an AI drug discovery startup, which is reportedly in talks for a $200 million funding round at a $2 billion valuation. This move highlights a growing trend of top AI talent migrating from large language model labs to scientific fields, particularly in areas like drug discovery. Investors are betting on the "AGI for Science" paradigm, valuing the talent and methodologies developed at leading AI labs as a new form of credentialing, rather than traditional industry experience. AI
IMPACT Accelerates the trend of top AI talent applying advanced models to scientific discovery, potentially revolutionizing drug development.
RANK_REASON Significant funding round for a startup founded by a prominent AI researcher, indicating a trend of talent migration to scientific applications. [lever_c_demoted from significant: ic=1 ai=0.7]
- AlphaFold
- Anthropic
- Chai Discovery
- Coefficient Bio
- Isomorphic Labs
- John Jumper
- Lightspeed
- Miles Wang
- OpenAI
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
